February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...
February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...
February 9, 2024 — BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is ...
February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s ...
February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...
February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...
February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American ...
February 7, 2024 — Eleven scientists leading the way in stroke research will be recognized during the American Stroke ...
February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...
February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...
February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...
February 09, 2024
